---
title: "Concord Healthcare Expands Mayo Clinic Partnership Into Full-Cycle Health Services"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283698789.md"
description: "Concord Healthcare Group Co., Ltd. has expanded its partnership with the Mayo Foundation for Medical Education and Research to include full-cycle health services. This agreement enhances their existing oncology collaboration by integrating Mayo’s health management systems and clinical expertise. The initiative aims to improve operational efficiency and patient experience, strengthening Concord's service capabilities from prevention to rehabilitation. The deal is expected to boost the company's competitiveness without being a notifiable transaction under listing rules. Concord Healthcare is a Hong Kong-listed oncology service provider focused on advanced cancer treatment technologies."
datetime: "2026-04-22T14:40:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283698789.md)
  - [en](https://longbridge.com/en/news/283698789.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283698789.md)
---

# Concord Healthcare Expands Mayo Clinic Partnership Into Full-Cycle Health Services

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ) just unveiled an update.

Concord Healthcare Group has signed a new cooperation agreement with the Mayo Foundation for Medical Education and Research that broadens their existing oncology-focused partnership into comprehensive life-cycle health services. The expanded collaboration will introduce Mayo’s health management systems, operational standards, and clinical know-how to Concord through remote planning, coaching workshops, on-site evaluations, and ongoing optimization.

The company expects the deal to strengthen its full-cycle service loop from prevention and screening to precision treatment and rehabilitation, improving medical capabilities, operational efficiency, and patient experience. Management believes the agreement, entered into on normal commercial terms and not constituting a notifiable or connected transaction under listing rules, will enhance Concord’s core competitiveness and align with the interests of shareholders and investors.

**More about Concord Healthcare Group Co., Ltd. Class H**

Concord Healthcare Group Co., Ltd. is a China-based oncology healthcare service provider, listed in Hong Kong, that serves cancer patients through its self-owned medical institutions and supports third-party hospitals with medical equipment, software, and related services. The group focuses on international-standard cancer diagnosis and treatment, leveraging advanced technologies such as proton therapy within the domestic healthcare market.

**Average Trading Volume:** 423,015

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$1.24B

Learn more about 2453 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [CCM.US](https://longbridge.com/en/quote/CCM.US.md)
- [02453.HK](https://longbridge.com/en/quote/02453.HK.md)

## Related News & Research

- [Concord Healthcare partners Uzbekistan health ministry to build, run Tashkent Gamma Knife center under PPP](https://longbridge.com/en/news/294176194.md)
- [09:02 ETTennessee Oncology Opens New State-of-the-Art Tullahoma Medical Center](https://longbridge.com/en/news/294697716.md)
- [NichiiGakkan signs cooperation pact with Aomori’s Sannohe Town on remote medical administration](https://longbridge.com/en/news/294472915.md)
- [Creative Solutions in Healthcare Renews Strategic Partnership with QRM Following Seven Years of Clinical & Operational Success.](https://longbridge.com/en/news/294421226.md)
- [15:15 ETHung Family's Generous Support Brings Advanced 3T MRI Technology to MemorialCare's Long Beach Medical Campus](https://longbridge.com/en/news/294248771.md)